GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2026)

GoodRx Holdings has disclosed Deferred Taxes across 8 years of filings, most recently posting $5.7 million for Q2 2026.

• In Q2 2026, Deferred Taxes changed N/A year-over-year to $5.7 million; the TTM figure through Jun 2026 stood at $29.8 million (up 350.52% YoY), while the FY2025 annual figure was $20.1 million, up 268.47% from the prior year.
• Deferred Taxes came in at $5.7 million for Q2 2026 at GoodRx Holdings, up from $4.1 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $12.0 million in Q4 2025 to a low of -$63.0 million in Q2 2023.
• Average Deferred Taxes over 5 years is -$3.4 million, with a median of $46500.0 recorded in 2022.
• The largest YoY upside for Deferred Taxes was 2459.49% in 2023 against a maximum downside of 108746.55% in 2023.
• Over 5 years, Deferred Taxes stood at -$356000.0 in 2022, then slumped by 2027.25% to -$7.6 million in 2023, then tumbled by 48.84% to -$11.3 million in 2024, then soared by 206.3% to $12.0 million in 2025, then slumped by 52.37% to $5.7 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were $5.7 million in Q2 2026, $4.1 million in Q1 2026, and $12.0 million in Q4 2025.